Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10963 | 1020 | 46.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
207 | 3 | MULTIPLE SCLEROSIS//MYASTHENIA GRAVIS//MULTIPLE SCLEROSIS JOURNAL | 52279 |
58 | 2 | MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA | 29459 |
10963 | 1 | MYELIN OLIGODENDROCYTE GLYCOPROTEIN//MULTIPLE SCLEROSIS//NEUROIMMUNOL | 1020 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MYELIN OLIGODENDROCYTE GLYCOPROTEIN | authKW | 552565 | 6% | 31% | 60 |
2 | MULTIPLE SCLEROSIS | authKW | 263059 | 42% | 2% | 426 |
3 | NEUROIMMUNOL | address | 169447 | 11% | 5% | 110 |
4 | PEPTIDE PROT CHEM BIOL | address | 151752 | 2% | 30% | 17 |
5 | INTRATHECAL IGG | authKW | 106908 | 0% | 71% | 5 |
6 | CLINICALLY ISOLATED SYNDROME | authKW | 99329 | 3% | 10% | 33 |
7 | AXONAL DAMAGE | authKW | 92566 | 2% | 13% | 23 |
8 | IGM OLIGOCLONAL BANDS | authKW | 89805 | 0% | 100% | 3 |
9 | NEUROIMMUNOL UNIT | address | 83161 | 6% | 5% | 57 |
10 | NEUROFILAMENT HEAVY CHAIN | authKW | 77192 | 1% | 37% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 7348 | 37% | 0% | 380 |
2 | Neurosciences | 5843 | 44% | 0% | 452 |
3 | Immunology | 4605 | 33% | 0% | 335 |
4 | Biochemical Research Methods | 144 | 5% | 0% | 50 |
5 | Medicine, Research & Experimental | 124 | 5% | 0% | 54 |
6 | Pathology | 102 | 4% | 0% | 36 |
7 | Biochemistry & Molecular Biology | 23 | 9% | 0% | 92 |
8 | Psychiatry | 13 | 2% | 0% | 25 |
9 | Medical Laboratory Technology | 7 | 1% | 0% | 7 |
10 | Pharmacology & Pharmacy | 5 | 4% | 0% | 43 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROIMMUNOL | 169447 | 11% | 5% | 110 |
2 | PEPTIDE PROT CHEM BIOL | 151752 | 2% | 30% | 17 |
3 | NEUROIMMUNOL UNIT | 83161 | 6% | 5% | 57 |
4 | CLIN NEUROIMMUNOL | 71265 | 3% | 8% | 29 |
5 | ORGAN CHEM UGO IFF | 69601 | 1% | 23% | 10 |
6 | NUBIN | 67352 | 0% | 75% | 3 |
7 | MUNICH GERMAN COMPETENCE NETWORK MULTIPLE SCLEROS | 59870 | 0% | 100% | 2 |
8 | PEPT UCP PLATFORM CHEM BIOL EA4505 | 59870 | 0% | 100% | 2 |
9 | SOSCO PEPT | 59870 | 0% | 100% | 2 |
10 | TRAUMA NEUROSCI | 59870 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROIMMUNOLOGY | 59911 | 11% | 2% | 116 |
2 | MULTIPLE SCLEROSIS JOURNAL | 49118 | 6% | 3% | 62 |
3 | MULTIPLE SCLEROSIS | 6470 | 1% | 2% | 11 |
4 | ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 6205 | 1% | 3% | 8 |
5 | ANNALS OF NEUROLOGY | 4941 | 4% | 0% | 36 |
6 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 4882 | 0% | 3% | 5 |
7 | MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2901 | 1% | 2% | 6 |
8 | JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 2364 | 1% | 1% | 7 |
9 | JOURNAL OF NEUROINFLAMMATION | 1771 | 1% | 1% | 10 |
10 | AUTOIMMUNITY REVIEWS | 1761 | 1% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYELIN OLIGODENDROCYTE GLYCOPROTEIN | 552565 | 6% | 31% | 60 | Search MYELIN+OLIGODENDROCYTE+GLYCOPROTEIN | Search MYELIN+OLIGODENDROCYTE+GLYCOPROTEIN |
2 | MULTIPLE SCLEROSIS | 263059 | 42% | 2% | 426 | Search MULTIPLE+SCLEROSIS | Search MULTIPLE+SCLEROSIS |
3 | INTRATHECAL IGG | 106908 | 0% | 71% | 5 | Search INTRATHECAL+IGG | Search INTRATHECAL+IGG |
4 | CLINICALLY ISOLATED SYNDROME | 99329 | 3% | 10% | 33 | Search CLINICALLY+ISOLATED+SYNDROME | Search CLINICALLY+ISOLATED+SYNDROME |
5 | AXONAL DAMAGE | 92566 | 2% | 13% | 23 | Search AXONAL+DAMAGE | Search AXONAL+DAMAGE |
6 | IGM OLIGOCLONAL BANDS | 89805 | 0% | 100% | 3 | Search IGM+OLIGOCLONAL+BANDS | Search IGM+OLIGOCLONAL+BANDS |
7 | NEUROFILAMENT HEAVY CHAIN | 77192 | 1% | 37% | 7 | Search NEUROFILAMENT+HEAVY+CHAIN | Search NEUROFILAMENT+HEAVY+CHAIN |
8 | OLIGOCLONAL BANDS | 76831 | 2% | 11% | 23 | Search OLIGOCLONAL+BANDS | Search OLIGOCLONAL+BANDS |
9 | MOG | 68703 | 1% | 15% | 15 | Search MOG | Search MOG |
10 | B CELLS | 62078 | 10% | 2% | 100 | Search B+CELLS | Search B+CELLS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAYER, MC , MEINL, E , (2012) GLYCOPROTEINS AS TARGETS OF AUTOANTIBODIES IN CNS INFLAMMATION: MOG AND MORE.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. VOL. 5. ISSUE 3. P. 147-159 | 54 | 78% | 31 |
2 | LEE, DH , LINKER, RA , (2012) THE ROLE OF MYELIN OLIGODENDROCYTE GLYCOPROTEIN IN AUTOIMMUNE DEMYELINATION: A TARGET FOR MULTIPLE SCLEROSIS THERAPY?.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 16. ISSUE 5. P. 451 -462 | 71 | 66% | 4 |
3 | FRAUSSEN, J , CLAES, N , DE BOCK, L , SOMERS, V , (2014) TARGETS OF THE HUMORAL AUTOIMMUNE RESPONSE IN MULTIPLE SCLEROSIS.AUTOIMMUNITY REVIEWS. VOL. 13. ISSUE 11. P. 1126 -1137 | 79 | 47% | 16 |
4 | WEBER, MS , HEMMER, B , CEPOK, S , (2011) THE ROLE OF ANTIBODIES IN MULTIPLE SCLEROSIS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1812. ISSUE 2. P. 239-245 | 59 | 63% | 41 |
5 | RAMANATHAN, S , DALE, RC , BRILOT, F , (2016) ANTI-MOG ANTIBODY: THE HISTORY, CLINICAL PHENOTYPE, AND PATHOGENICITY OF A SERUM BIOMARKER FOR DEMYELINATION.AUTOIMMUNITY REVIEWS. VOL. 15. ISSUE 4. P. 307 -324 | 60 | 51% | 3 |
6 | REINDL, M , KHALIL, M , BERGER, T , (2006) ANTIBODIES AS BIOLOGICAL MARKERS FOR PATHOPHYSIOLOGICAL PROCESSES IN MS.JOURNAL OF NEUROIMMUNOLOGY. VOL. 180. ISSUE 1-2. P. 50-62 | 64 | 57% | 44 |
7 | MAYER, MC , HOHLFELD, R , MEINL, E , (2012) VIABILITY OF AUTOANTIBODY-TARGETS: HOW TO TACKLE PATHOGENETIC HETEROGENEITY AS AN OBSTACLE FOR TREATMENT OF MULTIPLE SCLEROSIS.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 319. ISSUE 1-2. P. 2-7 | 40 | 77% | 4 |
8 | PIKOR, N , GOMMERMAN, JL , (2012) B CELLS IN MS: WHY, WHERE AND HOW?.MULTIPLE SCLEROSIS AND RELATED DISORDERS. VOL. 1. ISSUE 3. P. 123-130 | 50 | 60% | 2 |
9 | HOHLFELD, R , DORNMAIR, K , MEINL, E , WEKERLE, H , (2016) THE SEARCH FOR THE TARGET ANTIGENS OF MULTIPLE SCLEROSIS, PART 2: CD8+T CELLS, B CELLS, AND ANTIBODIES IN THE FOCUS OF REVERSE-TRANSLATIONAL RESEARCH.LANCET NEUROLOGY. VOL. 15. ISSUE 3. P. 317 -331 | 53 | 34% | 6 |
10 | FIALOVA, L , BARTOS, A , SVARCOVA, J , ZIMOVA, D , KOTOUCOVA, J , MALBOHAN, I , (2013) SERUM AND CEREBROSPINAL FLUID LIGHT NEUROFILAMENTS AND ANTIBODIES AGAINST THEM IN CLINICALLY ISOLATED SYNDROME AND MULTIPLE SCLEROSIS.JOURNAL OF NEUROIMMUNOLOGY. VOL. 262. ISSUE 1-2. P. 113-120 | 35 | 70% | 12 |
Classes with closest relation at Level 1 |